Current and Emerging Antibiofilm Strategies

Biofilm is a common culprit of stalled wound healing. The Centers for Disease Control and Prevention (CDC) estimate bacteria that generate biofilm cause 65% of all human infectious diseases. This white paper will detail strategies and products to manage biofilm, such as debridement, negative pressure wound therapy with instillation (NPWTi), bacteriophage therapy, nanomaterials, blue light therapy, quorum-sensing inhibitors, matrix-degrading enzymes, peptides, medical honey, and surfactants.